{'fraction_non_alphanumeric': 0.02585034013605442, 'fraction_numerical': 0.04625850340136054, 'mean_word_length': 6.0095238095238095, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Highlights From the Circulation Family of Journals.

Circulation. 2019;139:2064–2068. DOI: 10.1161/CIRCULATIONAHA.119.041038 2064 This post hoc analysis from the DANISH trial (Danish Study to Assess the Efficacy of ICDs in Patients with Nonischemic Systolic Heart Failure on Mortality) evaluated whether right ventricular failure can identify patients with nonischemic systolic heart failure who are more likely to benefit from implantable cardioverter-defibrillator (ICD) implantation. There was an independent association of right ventricular systolic dysfunction with mortality and a significant interaction with ICD therapy, suggesting a possible survival benefit with ICD implantation in patients with biventricular heart failure.